IC
IDYA icon

Innealta Capital’s IDEAYA Biosciences IDYA Stock Holding History

Innealta Capital’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-18
Closed -$632 – 875
2024
Q2 		$632 Buy
+18
New +$713 ﹤0.01% 1425

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Innealta Capital's IDYA Position: Q3 2024 in Review

Innealta Capital sold out of IDEAYA Biosciences (IDYA) in Q3 2024, closing a stake of 18 shares — an estimated $632 sold.

Innealta Capital first reported a position in IDYA in Q2 2024 and held it in 1 quarter. The position peaked at $632 in Q2 2024. 209 funds tracked by Wall St. Rank hold IDYA as of Q3 2024.

  • Innealta Capital reported no remaining IDEAYA Biosciences position as of Q3 2024 after selling out during the quarter.
  • Innealta Capital sold 18 IDEAYA Biosciences shares in Q3 2024, an estimated $632.
  • Innealta Capital first reported a position in IDEAYA Biosciences in Q2 2024 and held it in 1 quarter.
  • Innealta Capital's IDEAYA Biosciences position peaked at $632 in Q2 2024.
  • 209 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2024.

Based on Innealta Capital's 13F filing for Q3 2024, filed 29 Oct 2024.